Patents by Inventor Brian M. Olson

Brian M. Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROSTATE CANCER VACCINE
    Publication number: 20200138925
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: January 17, 2020
    Publication date: May 7, 2020
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Prostate cancer vaccine
    Patent number: 10561716
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: October 19, 2018
    Date of Patent: February 18, 2020
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Douglas G. McNeel, Brian M. Olson
  • PROSTATE CANCER VACCINE
    Publication number: 20190038732
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 7, 2019
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Prostate cancer vaccine
    Patent number: 10111940
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: August 16, 2016
    Date of Patent: October 30, 2018
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Douglas G. McNeel, Brian M. Olson
  • PROSTATE CANCER VACCINE
    Publication number: 20170014498
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: August 16, 2016
    Publication date: January 19, 2017
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Prostate cancer vaccine
    Patent number: 9433668
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: February 4, 2015
    Date of Patent: September 6, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Douglas G. McNeel, Brian M. Olson
  • PROSTATE CANCER VACCINE
    Publication number: 20150306197
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: February 4, 2015
    Publication date: October 29, 2015
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Prostate cancer vaccine
    Patent number: 8962590
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: August 16, 2013
    Date of Patent: February 24, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Douglas G. McNeel, Brian M. Olson
  • PROSTATE CANCER VACCINE
    Publication number: 20140105853
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: August 16, 2013
    Publication date: April 17, 2014
    Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Prostate cancer vaccine
    Patent number: 8513210
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: February 21, 2011
    Date of Patent: August 20, 2013
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Douglas G. McNeel, Brian M. Olson
  • PROSTATE CANCER VACCINE
    Publication number: 20120020912
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Application
    Filed: February 21, 2011
    Publication date: January 26, 2012
    Applicant: WISCONSIN ALUMINI RESEARCH FOUNDATION
    Inventors: Douglas G. McNeel, Brian M. Olson
  • Prostate cancer vaccine
    Patent number: 7910565
    Abstract: Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: March 22, 2011
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Douglas G. McNeel, Brian M. Olson